Spinal fusion devices market projected to hit $11.09 billion by 2035

Market Research Future projects the global spinal fusion devices market will grow from $6.35 billion in 2026 to $11.09 billion by 2035. Aging populations, robotic-assisted surgery, and wider outpatient reimbursement are expected to drive demand across hospitals and ambulatory surgery centers.

Why it matters: - The spinal fusion devices market is moving from a niche implant category to a core part of orthopedic surgery infrastructure. - Aging populations, degenerative spine disease, and reimbursement shifts are expanding procedure volume and device demand through 2035. - Outpatient migration is also changing where procedures happen, which affects purchasing, implant design, and hospital investment priorities.

What happened: - Market Research Future said the global spinal fusion devices market will rise from $6.35 billion in 2026 to $11.09 billion by 2035. - The forecast implies a 6.40% compound annual growth rate from 2026 to 2035. - The market was estimated at $5.97 billion in 2025. - The estimate was released July 14, 2026. - The report said a free sample is available here.

The details: - The World Health Organization projects the global population aged 60 and over will reach 1.4 billion by 2030 and 2.1 billion by 2050. - In the U.S., degenerative disc disease affects an estimated 40% of adults over 40 and 80% of adults over 80. - The U.S. performs about 500,000 spinal fusion procedures a year. - Robotic spine platforms from Medtronic, Globus Medical and Stryker have achieved pedicle-screw placement accuracy above 96%. - Those systems have cut revision rates by about 50% versus freehand techniques. - The market has attracted more than $1.8 billion in cumulative venture and strategic investment since 2020. - CMS has approved more than a dozen new outpatient fusion DRG codes since 2021. - Effective January 2026, CMS phased out the Inpatient Only list and removed more than 75 spine and cranial procedures. - Medicare added more than 100 complex spine codes, including posterior lumbar interbody fusions, to the Ambulatory Surgical Center Covered Procedures List. - The U.K. NHS has committed GBP 8 billion to elective surgery recovery through 2026. - China’s 14th Five-Year Plan hospital upgrades and India’s Ayushman Bharat expansion are widening access to surgery.

Between the lines: - The market’s growth is being shaped by three forces at once: older patients, more precise surgery, and payment policies that favor outpatient care. - Robotic systems tend to pull implant purchases into proprietary ecosystems, which can lock facilities into single-vendor supply chains. - The report’s numbers suggest volume growth will be strongest where hospitals already have surgeons, capital equipment, and reimbursement support in place. - Competitive advantage is shifting away from price alone and toward robotic platforms, 3-D-printed implants, and surgeon training networks.

What's next: - Market Research Future expects autonomous robotic surgery and closed-loop navigation to advance toward 2030. - The report forecasts more real-time intraoperative feedback, including screw trajectory adjustments based on bone density mapping and neural monitoring data. - Additive manufacturing and patient-specific implants are expected to lower per-procedure costs and widen adoption beyond tertiary hospitals. - Bioresorbable materials are still moving through regulatory pathways, but they could broaden the market further if they prove safe and effective. - The report says 3-D-printed implants are already gaining traction, with the FDA clearing more than 120 distinct orthopedic spine implants since 2016.

The bottom line: - Spinal fusion devices are poised for steady growth as aging demographics, robotic surgery, and outpatient reimbursement reinforce each other across the next decade.